Paul Tudor Jones’s Soleno Therapeutics SLNO Stock Holding History

Paul Tudor Jones’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,300	Closed	-$569K	–	4216
2025 Q4	$569K	Sell	12,300 -13,100	-52%	-$718K	﹤0.01%	2652
2025 Q3	$1.72M	Buy	25,400 +21,900	+626%	+$1.62M	﹤0.01%	1903
2025 Q2	$293K	Buy	+3,500	New	+$262K	﹤0.01%	2902

Paul Tudor Jones's SLNO Position: Q2 2026 in Review

Paul Tudor Jones sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 56,118 shares — an estimated $1.88M sold.

Paul Tudor Jones first reported a position in SLNO in Q1 2024 and held it in 4 quarters. The position peaked at $2.11M in Q3 2024. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Paul Tudor Jones reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 56,118 Soleno Therapeutics shares in Q2 2026, an estimated $1.88M.
Paul Tudor Jones first reported a position in Soleno Therapeutics in Q1 2024 and held it in 4 quarters.
Paul Tudor Jones's Soleno Therapeutics position peaked at $2.11M in Q3 2024.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.